AU Patent

AU2016202397B2 — Method and system for the treatment of chronic obstructive pulmonary disease with nebulized anticholinergic administrations

Assigned to Sunovion Respiratory Development Inc · Expires 2018-03-15 · 8y expired

What this patent protects

Inhalation solutions for administration of muscarinic antagonists for the treatment of breathing disorders, such as COPD, are provided.

USPTO Abstract

Inhalation solutions for administration of muscarinic antagonists for the treatment of breathing disorders, such as COPD, are provided.

Drugs covered by this patent

Patent Metadata

Patent number
AU2016202397B2
Jurisdiction
AU
Classification
—
Expires
2018-03-15
Drug substance claim
No
Drug product claim
No
Assignee
Sunovion Respiratory Development Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.